Kenshiro Yamamoto

Kenshiro Yamamoto

Auto-generated profile, based on publicly available information

Kenshiro Yamamoto

Affiliation Department of Cardiology, NHO Kanazawa Medical Center, Kanazawa, Ishikawa, Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Circulation Journal
Verified
Journal Article
Open access
PDF file
STShogo Tanno
Shogo Tanno
KYKenshiro Yamamoto
Kenshiro Yamamoto
YKYasutaka Kurata
Yasutaka Kurata
MAMaya Adachi
Maya Adachi
YIYumiko Inoue
Yumiko Inoue
IHIchiro Hisatome
Ichiro Hisatome
Background:Ischemia/reperfusion (I/R) injury triggers cardiac dysfunctions via creating reactive oxygen species (ROS). Because xanthine oxidase (XO) is one of the major enzymes that generate ROS, inhibition of XO is expected to suppress ROS-induced I/R injury. However, it remains unclear whether XO inhibition really yields cardioprotection during I/R. The protective effects of the XO inhibitors, topiroxostat and allopurinol, on cardiac I/R injury were evaluated.Methods and Results:Using isolated rat hearts, ventricular functions, occurrence of arrhythmias, XO activities and thiobarbituric acid reactive substances (TBARS) productions and myocardial levels of adenine nucleotides before and after I/R, and cardiomyocyte death markers during reperfusion, were evaluated. Topiroxostat prevented left ventricular dysfunctions and facilitated recovery from arrhythmias during I/R. Allopurinol and the antioxidant, N-acetylcysteine (NAC), exhibited similar effects at higher concentrations. Topiroxostat inhibited myocardial XO activities and TBARS productions after I/R. I/R decreased myocardial levels of ATP, ADP and AMP, but increased that of xanthine. While topiroxostat, allopurinol or NAC did not change myocardial levels of ATP, ADP or AMP after I/R, all of the agents decreased the level of xanthine. They also decreased releases of CPK and LDH during reperfusion.Conclusions:Topiroxostat showed protective effects against I/R injury with higher potency than allopurinol or NAC. It dramatically inhibited XO activity and TBARS production, suggesting suppression of ROS generation.

28 May 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MNMisaki Nakamura
Misaki Nakamura
KYKanako Yamamoto
Kanako Yamamoto
SNShinichi Nozaki
Shinichi Nozaki
TSTakahiro Saeki
Takahiro Saeki
WOWataru Omi
Wataru Omi
SSSatoru Sakagami
Satoru Sakagami
Low body weight is associated with decreased capacity for performing activities of daily living (ADLs) after discharge in patients with heart failure (HF). In particular, malnutrition and low body mass index (BMI) are considered poor prognostic factors. In this study, we aimed to examine the relationship between oral function and low body weight as well as the ability to perform ADLs in older patients with HF. To this end, we retrospectively examined patients with HF aged 75 years or older who had undergone oral function assessments. We examined various factors including age, sex, BMI, brain natriuretic peptide (BNP) levels, left ventricular ejection fraction (LVEF), Oral Health Assessment Tool-Japanese version (OHAT-J) scores, Barthel Index (BI) scores, and length of hospital stay. Patients were categorized into two groups based on their OHAT-J scores (OHAT-J ≤ 2 or OHAT-J ≥ 3), and their characteristics, including individual survey items, were compared. Additional correlation analyses were performed for BI at discharge. We found a negative correlation between the total OHAT-J score and BI at discharge. Specifically, lower BIs at discharge were observed in the group with poor scores for the items “lips,” “saliva,” and “dentures.” Oral dysfunction was associated with decreased ability to perform ADLs at discharge in older patients with HF. Thus, interdisciplinary interventions targeting oral health may improve the prognosis of patients with HF.